BG

Bellevue Group Portfolio holdings

AUM $4.54B
1-Year Est. Return 22.5%
This Quarter Est. Return
1 Year Est. Return
+22.5%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$10.2B
AUM Growth
+$793M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
228
New
Increased
Reduced
Closed

Top Buys

1
+$72M
2
+$48M
3
+$42.6M
4
ADPT icon
Adaptive Biotechnologies
ADPT
+$39.3M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$39M

Top Sells

1
+$238M
2
+$62.9M
3
+$45.4M
4
BMY icon
Bristol-Myers Squibb
BMY
+$41.5M
5
DVA icon
DaVita
DVA
+$39.6M

Sector Composition

1 Healthcare 96.41%
2 Industrials 0.94%
3 Technology 0.31%
4 Financials 0.04%
5 Consumer Discretionary 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$597M 5.83%
2,542,300
-267,650
2
$396M 3.87%
9,930,245
+946,011
3
$350M 3.41%
1,733,694
+356,990
4
$294M 2.87%
3,017,751
-256,800
5
$293M 2.86%
974,038
+19,484
6
$263M 2.56%
1,549,092
-78,022
7
$250M 2.44%
2,971,400
-34,300
8
$240M 2.34%
4,352,992
-184,100
9
$227M 2.21%
2,613,536
+404,200
10
$198M 1.93%
7,376,026
+1,348,100
11
$186M 1.81%
606,285
-56,040
12
$183M 1.79%
528,100
-30,300
13
$178M 1.74%
465,976
+80,428
14
$172M 1.68%
2,237,403
+165,900
15
$160M 1.56%
1,377,499
-15,500
16
$157M 1.53%
966,884
-11,500
17
$147M 1.44%
3,609,919
-50,000
18
$137M 1.34%
7,531,414
19
$137M 1.34%
343,051
-14,330
20
$134M 1.31%
2,364,204
+553,500
21
$130M 1.27%
544,756
+11,054
22
$125M 1.22%
282,755
-5,964
23
$120M 1.17%
5,269,039
+75,000
24
$112M 1.09%
472,489
25
$110M 1.07%
1,730,471
+274,197
1
2 3 4 5